IRadimed Analyst Ratings
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Raises Target Price to $70
Roth MKM Maintains IRadimed(IRMD.US) With Buy Rating, Raises Target Price to $72
Wall Street Analysts Are Bullish on Top Healthcare Picks
Lake Street Initiates IRadimed(IRMD.US) With Buy Rating, Announces Target Price $70
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Iradimed (IRMD) Gets a Buy From Lake Street
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Lake Street Reaffirms Their Buy Rating on Iradimed (IRMD)
IRadimed Analyst Ratings
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Roth MKM Maintains IRadimed(IRMD.US) With Buy Rating, Cuts Target Price to $60
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $60